Abstract
The cerebral pharmacokinetics and pharmacodynamics of midazolam and diazepam were examined in chronically instrumented sheep via measurements of their arterio-venous concentration difference across the brain during and after 2-min iv infusions. Diazepam (30 mg) or midazolam (10 mg) were administered on 5 separate occasions to 4 sheep. For both drugs, rapid cerebral uptake occurred during the infusion, which quickly turned to elution in the postinfusion period. However, this process was more rapid for midazolam than diazepam. The cerebral pharmacokinetics of both was better described by a kinetic model with slight membrane limitation rather than flow limitation. For diazepam, the estimated brain:plasma partition coefficient was 2.67, and the first and second compartments filled with half-lives of 2.2 and 0.5 min, respectively. For midazolam, these values were 0.27, 0.26 and 1.34 min, respectively. In a subset of sheep, pulmonary arterial–arterial gradients were too small to measure suggesting limited metabolism and small distribution volumes for both drugs in the lungs. Simultaneous dynamic measurements of cerebral blood flow and algesimetry lagged behind both the arterial and sagittal sinus blood concentrations. The changes in cerebral blood flow were best described by a previously published a dynamic model that incorporated long half-lives for drug dissociation from the benzodiazepine receptor (13.3 and 5.5 min for midazolam and diazepam, respectively). Effect compartment modeling of the cerebral blood flow data showed apparent effect compartment half-lives (t1/2,keo) that were longer than the half-lives of cerebral equilibration.
Similar content being viewed by others
REFERENCES
A. Nilsson. Benzodiazepines and their reversal. In B. Kay (ed.), Total Intravenous Anaes-thesia. Monographs in Anaesthesiology, Vol. 21, Elsevier, Amsterdam, 1991, pp. 57–80.
M. Wood. Intravenous anesthetic agents. In M. Wood and A. J. J. Wood (eds), Drugs and Anesthesia. Pharmacology for Anesthetists. Williams and Wilkins, Baltimore, 1990, pp. 179–224.
J. R. Jacobs and J. G. Reves. Effect site equilibration time is a determinant of induction dose requirement. Anesth. Analg. 76:1–6 (1993).
R. N. Upton and G. L. Ludbrook. A model of the kinetics and dynamics of the induction of anesthesia in sheep. Variable estimation for thiopentone and comparison with propofol. Br. J. Anaesth. 82:890–903 (1999).
M. Buhrer, P. O. Maitre, C. Crevoisier, and D. R. Stanski. Electroencephalographic effects of benzodiazepines. II. Pharmacodynamic modeling of the electroencephalographic effects of midazolam and diazepam. Clin. Pharmacol. Ther. 48:555–567 (1990).
M. L. Jack, W. A. Colburn, N. M. Spirt, G. Bautz, M. Zanko, W. D. Horst, and R. A. O'Brien. A pharmacokinetic/pharmacodynamic/receptor binding model to predict the onset and duration of pharmacological activity of benzodiazepines. Prog. Neuropsycho-pharmacol. Biol. Psychiat. 7:629–635 (1983).
R. N. Upton, G. L. Ludbrook, C. Grant, and E. C. Gray. In vivo relationships between the cerebral pharmacokinetics and pharmacodynamics of thiopentone in sheep after short-term administration. J. Pharmacokin. Biopharm. 24:1–18 (1996).
G. L. Ludbrook, R. N. Upton, C. Grant, and E. C. Gray. The blood and brain concen-trations of propofol after rapid intravenous injection in sheep, and their relationships to cerebral effects. Anaesth. Intens. Care 24:445–452 (1996).
R. N. Upton, C. Grant, and G. L. Ludbrook. An ultrasonic Doppler venous outflow method for the continuous measurement of cerebral blood flow in conscious sheep. J. Cerebral Blood Flow Metab. 14:680–688 (1994).
D. J. Doolette, R. N. Upton, and C. Grant. Agreement between estimates of cerebral blood flow changes in the sheep by a real-time ultrasonic Doppler venous outflow method and Kety Schmidt calculations based on 15 minutes nitrous oxide wash-in. Clin. Exp. Pharmacol. Physiol. 26:736–740 (1999).
W. B. Runciman, A. H. Ilsley, L. E. Mather, R. J. Carapetis, and M. M. Rao. A sheep preparation for studying interactions between blood flow and drug disposition I: Physio-logical profile. Br. J. Anaesth. 56:1015–1028 (1984).
C. Grant, R. N. Upton, and T. R. Kuchel. An assessment of the efficacy of intramuscular analgesics for acute pain in the sheep. Aust. Vet. J. 73:129–132 (1996).
Y.F. Huang, R.N. Upton, D. Zheng, C. McLean, E.C. Gray, and C. Grant. The enanti-omer specific kinetics and dynamics of verapamil after rapid intravenous administration to sheep—Physiological analysis and modeling. J. Pharm. Exp. Ther. 284:1048–1057 (1998).
G. L. Ludbrook, C. Grant, R. N. Upton, and C. Penhall. A method for frequent measure-ment of sedation and analgesia in sheep using the response to a ramped electrical stimulus. J. Pharmacol. Toxicol. Methods. 33:17–22 (1995).
R. N. Upton and G. L. Ludbrook. A physiological model of the induction of anesthesia with propofol in sheep. 1. Structure and estimation of parameters. Br. J. Anaesth. 79:497–504 (1997).
R. N. Upton, Y. F. Huang, L. E. Mather, and D. J. Doolette. The relationship between the myocardial kinetics of meperidine and its effect on myocardial contractility—Model independent analysis and optimal regional model. J. Pharmacol. Exp. Ther. 290:694–701 (1999).
H. Motulsky. Intuitive Biostatistics. Oxford University Press, New York, 1995, pp. 63–69.
D. L. Roerig, R. R. Dahl, C. A. Dawson, and R. I. Wang. Effect of plasma protein binding on the uptake of methadone and diazepam in the isolated perfused rat lung. Drug. Metab. Dispos. 12:536–542 (1984).
R.M. Arendt, D.J. Greenblatt, R.H. deJong, J.D. Bonin, D.R. Abernethy, B.L. Ehrenberg, H.G. Giles, E.M. Sellers and R.I. Shader. In vitro correlates of benzodiazepine cerebral spinal fluid uptake, pharmacodynamic action and peripheral distribution. J. Pharm. Exp. Ther. 227:98–106 (1983).
H. Freidman, D. R. Abernathy, D. J. Greenblatt and R. I. Shader. The pharmacokinetics of diazepam and desmethyldiazepam in rat brain and plasma. Psychopharmacology 88:267–270 (1986).
D. J. Greenblatt, H. R. Ochs, and B. L. Lloyd. Entry of diazepam and its major metabolite into cerebrospinal fluid. Psychopharmacology 70:89–93 (1980).
S. Bjorkman, J. Akeson, F. Nilsson, K. Messeter, and B. Roth. Ketamine and midazolam decrease cerebral blood flow and consequently their own rate of transport to the brain: An application of mass balance pharmacokinetics with a changing regional blood flow. J. Pharmacokin. Biopharm. 20:637–652 (1992).
Y. Igari, Y. Sugiyama, Y. Sawada, T. Iga, and M. Hanano. Prediction of diazepam dispo-sition in the rat and man by a physiologically based pharmacokinetic model. J. Pharmaco-kin. Biopharm. 11:577–593 (1983).
R. M. Arendt, D. J. Greenblatt, D. C. Liebisch, M. D. Luu, and S. M. Paul. Determinants of benzodiazepine brain uptake: lipophilicity vs. binding affinity. Psychopharmacology 93:72–76 (1987).
J. M. Scavone, H. Friedman, D. J. Greenblatt, and R. I. Shader. Effect of age, body composition, and lipid solubility on benzodiazepine tissue distribution in rats. Arzneim. Forsch. 37:1–6 (1987).
S. Bjorkman, A. Fyge, and Q. Zhongquan. Determination of steady state tissue distri-bution of midazolam in the rat. J. Pharm. Sci. 85:887–889 (1996).
T. N. Tozer. Concepts basic to pharmacokinetics. Pharmac. Ther. 14:109–131 (1981).
J. W. Mandema, L. N. Sansom, M. C. Dios-Vieitez, M. Hollander-Jansen, and M. Danhof. Pharmacokinetic-pharmacodynamic modeling of the electroencephalographic effects of benzodiazepines. Correlation with receptor binding and anticonvulsant activity. J. Pharma-col. Exp. Ther. 257:472–478 (1991).
C. Hoyo-Vadillo, J. W. Mandema, and M. Danhof. Pharmacodynamic interaction between midazolam and a low dose of ethanol in vivo. Life Sci. 57:325–333 (1995).
H. Allonen, G. Ziegler, and U. Klotz. Midazolam kinetics. Clin. Pharmacol. Ther. 30:653–661 (1981).
J. W. Mandema, B. Tuk, A. L. van Steveninck, D.D. Breimer, A. F. Cohen, and M. Danhof. Pharmacokinetic-pharmacodynamic modeling of the central nervous system effects of midazolam and its main metabolite alpha-hydroxymidazolam in healthy volunteers. Clin. Pharmacol. Ther. 51:715–728 (1992).
S. Hovinga, A. M. Stijnen, M. W. Langemeijer, J. W. Mandema, C. F. van Bezooijen, and M. Danhof. Pharmacokinetic-EEG effect relationship of midazolam in aging BN/BiRij rats. Br. J. Pharmacol. 107:171–177 (1992).
P. O. Maitre, B. Funk, C. Crevoisier, and H. R. Ha. Pharmacokinetics of midazolam in patients recovering from cardiac surgery. Eur. J. Clin. Pharmacol. 37:161–166 (1989).
U. Klotz, K. H. Antonin, and P. R. Bieck. Pharmacokinetics and plasma binding of diazepam in man, dog, rabbit, guinea pig and rat. J. Pharm. Exp. Ther. 199:67–73 (1976).
T. H. Lin and J. H. Lin. Effects of protein binding and experimental disease states on brain uptake of benzodiazepines in rats. J. Pharmacol. Exp. Ther. 253:45–50 (1990).
C. Dagenais, C. Rousselle, G. M. Pollack, and J. M. Scherrmann. Development of an in situ mouse brain perfusion model and its application to mdr1a p-glycoprotein-deficient mice. J. Cerebral. Blood Flow Metab. 20:381–386 (2000).
E. G. Schuetz, W. T. Beck, and J. D. Schuetz. Modulators and substrates of p-glycoprotein and cytochrome P4503A coordinately up-regulate these proteins in human colon carcinoma cells. Mol. Pharmacol. 49:311–318 (1996).
S. P. Letrent, G. M. Pollack, K. R. Brouwer, and K. L. Brouwer. Effects of a potent and specific p-glycoprotein inhibitor on the blood–brain barrier distribution and antinocicep-tive effect of morphine in the rat. Drug Metab. Dispos. 27:827–834 (1999).
D. J. Greenblatt, B. L. Ehrenberg, J. Gunderman, A. Locniskar, J. M. Scavone, J. S. Harmatz, and R.I. Shader. Pharmacokinetic and electroencephalographic study of intra-venous diazepam, midazolam, and placebo. Clin. Pharmacol. Ther. 45:356–365 (1989).
D. R. Mould, T. M. DeFeo, S. Reele, G. Milla, R. Limjuco, T Crews, N. Choma, and I.H. Patel. Simultaneous modeling of the pharmacokinetics and pharmacodynamics of midazolam and diazepam. Clin. Pharmacol. Ther. 58:35–43 (1995).
D. R. Stanski, R. J. Hudson, T. D. Homer, L. J. Saidman, and E. Meathe. Pharmacodyn-amic modeling of thiopental anesthesia. J. Pharmacokinet. Biopharm. 12:22–240 (1984).
B. Tuk, V. M. M. Herben, J. W. Mandema, and M. Danhof. Relevance of arteriovenous concentration differences in pharmacokinetic-pharmacodynamic modeling of midazolam. J. Pharm. Exp. Ther. 284:202–207 (1998).
P. Fiset, H. L. Lemmens, T. E. Egan, S. L. Shafer, and D. R. Stanski. Pharmacodynamic modeling of the electroencephalographic effects of flumazenil in healthy volunteers sedated with midazolam. Clin. Pharmacol. Ther. 58:567–582 (1995).
J. C. Connelly and J. W. Bridges. The distribution and role of cytochrome P-450 in extra-hepatic organs. In: J. W. Bridges and L. F. Chasseaud (eds), Progress in Drug Metabolism, Vol. 5. Wiley, Chichester, 1980, pp. 2–89.
Rights and permissions
About this article
Cite this article
Upton, R.N., Ludbrook, G.L., Grant, C. et al. In vivo Cerebral Pharmacokinetics and Pharmaco-dynamics of Diazepam and Midazolam after Short Intravenous Infusion Administration in Sheep. J Pharmacokinet Pharmacodyn 28, 129–153 (2001). https://doi.org/10.1023/A:1011550915515
Issue Date:
DOI: https://doi.org/10.1023/A:1011550915515